Pulmonary Rehabilitation
-
SOAR Act in limbo while legislators ride out government shutdown
CHEST Past President John E. Studdard, MD, Master FCCP, said the biggest impact of Medicare competitive bidding has been reduced reimbursement, which has slowed innovation in oxygen delivery.
-
Debate to consider potential answers to pulmonary rehabilitation issues
Malik Khurram Khan, MD, FCCP, will chair a Tuesday morning pro-con debate session that will address uncertainty about the use of telemedicine and personalization in pulmonary rehabilitation.
-
Hope on the horizon for bronchiectasis
The combination of personalized therapies, novel and repurposed medications, and a multidisciplinary approach is transforming bronchiectasis from a condition that once had few treatment options into one that offers hope for improved management and even disease stabilization.
-
Athletes require special considerations for everything from respiratory viruses to cardiovascular concerns
Eli Friedman, MD, said that when treating athletes, clinicians must consider their unique needs and how their high activity levels may impact their health care journey.
-
Navigating new ACR/CHEST guidelines for screening, monitoring, and treatment of SARD-ILD
Authors Jose R. Castellanos, MD; Anthony J. Esposito, MD; and Caroline Zhao, MD, discuss key strategies, including early screening with pulmonary function tests and high-resolution chest tomography, cautious glucocorticoid use, and personalized steroid-sparing treatment.
